Engineered immune cells targeted and reduced the toxic protein plaques that drive Alzheimer’s disease in a recent study.

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...

WASHINGTON — The Department of Veterans Affairs will launch its first clinical study since the 1960s into the effectiveness of psychedelic drugs as a treatment for post-traumatic stress disorder, the ...

FAYETTEVILLE, N.C. – Army veteran Joe Aguirre opens a restaurant door, then steps aside to let his golden retriever take point. "Clear," Aguirre commands, and 3-year-old Munger pivots right, left, ...

It's well-documented that Paxlovid — a 5-day course of antiviral pills from Pfizer — can reduce the risk of hospitalization in COVID-19 patients who are more likely to develop severe illness. Now, ...

Add Yahoo as a preferred source to see more of our stories on Google. Key senators, including the chairman of the Senate Veterans Affairs Committee, are renewing a push for an in-depth study of how ...

Press release provided by the U.S. Dept. of Veterans Affairs A study published today in the August issue of the journal Health Affairs by U.S. Department of Veterans Affairs (VA) and led by University ...

A patient walks down a hallway at the Fayetteville Veterans Affairs Medical Center in North Carolina in March 2015. A national study found VA hospitals often meet or exceed the quality of other ...

According to the U.S. Department of Veterans Affairs, the suicide rate for veterans was 57 percent higher in 2020 than it was for non-veteran adults. And in Oregon, that disparity was even greater.